Re-irradiation with concurrent pembrolizumab for local-regionally recurrent squamous cell carcinoma of the head and neck

Re-irradiation with concurrent pembrolizumab for local-regionally recurrent squamous cell carcinoma of the head and neck

Purpose: To report a single institutional experience with re-irradiation and concurrent pembrolizumab for local-regionally recurrent squamous cell carcinoma of the head and neck. Method and materials: A total of 16 patients were treated with external-beam re-irradiation to median dose of 66 Gy with...

Full description

Saved in:
Bibliographic Details
Main Authors: Allen M. Chen, Jeremy P. Harris, Rupali Nabar, Tjoson Tjoa, Yarah Haidar, William B. Armstrong
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Oral Oncology Reports
Subjects:
Re-irradiation
Recurrent
Head and neck cancer
Pembrolizumab
Immunotherapy
Online Access:http://www.sciencedirect.com/science/article/pii/S2772906025000020
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items